2023 Q2 Form 10-Q Financial Statement

#000002523223000035 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $204.3M $202.7M
YoY Change 10.04% 8.47%
Cost Of Revenue $67.58M $71.21M
YoY Change 8.61% 9.77%
Gross Profit $136.7M $131.5M
YoY Change 10.76% 7.78%
Gross Profit Margin 66.93% 64.87%
Selling, General & Admin $8.180M $8.645M
YoY Change 6.61% 2.64%
% of Gross Profit 5.98% 6.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.27M $75.77M
YoY Change 14.9% 7.1%
% of Gross Profit 58.7% 57.61%
Operating Expenses $88.45M $84.42M
YoY Change 14.08% 6.63%
Operating Profit $48.30M $130.1M
YoY Change -60.75% 8.8%
Interest Expense -$25.97M $25.03M
YoY Change -256.94% 61.22%
% of Operating Profit -53.78% 19.23%
Other Income/Expense, Net
YoY Change
Pretax Income $22.32M $21.68M
YoY Change -22.71% -19.81%
Income Tax
% Of Pretax Income
Net Earnings $22.62M $22.20M
YoY Change -33.57% -20.68%
Net Earnings / Revenue 11.07% 10.95%
Basic Earnings Per Share $0.15 $0.15
Diluted Earnings Per Share $0.15 $0.15
COMMON SHARES
Basic Shares Outstanding 151.7M shares 151.5M shares
Diluted Shares Outstanding 152.1M shares 151.9M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.031M $3.585M
YoY Change 97.95% -48.79%
Cash & Equivalents $8.031M $3.585M
Short-Term Investments
Other Short-Term Assets $16.63M $11.78M
YoY Change 46.77% -11.99%
Inventory
Prepaid Expenses
Receivables $12.47M $9.634M
Other Receivables $196.3M $192.7M
Total Short-Term Assets $233.5M $217.7M
YoY Change 21.77% 10.14%
LONG-TERM ASSETS
Property, Plant & Equipment $7.034B $7.034B
YoY Change 2.08% 2.32%
Goodwill $1.674M $1.674M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $139.0M $136.7M
YoY Change 34.66% 46.53%
Other Assets $67.34M $64.81M
YoY Change 58.16% 87.17%
Total Long-Term Assets $7.362B $7.365B
YoY Change 2.42% 2.83%
TOTAL ASSETS
Total Short-Term Assets $233.5M $217.7M
Total Long-Term Assets $7.362B $7.365B
Total Assets $7.596B $7.583B
YoY Change 2.92% 3.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $241.6M $205.0M
YoY Change 15.9% 6.76%
Accrued Expenses $53.32M $53.23M
YoY Change 7.97% 7.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $294.9M $258.2M
YoY Change 14.38% 6.99%
LONG-TERM LIABILITIES
Long-Term Debt $2.424B $2.449B
YoY Change 5.12% 4.23%
Other Long-Term Liabilities $272.8M $254.7M
YoY Change 48.29% 36.52%
Total Long-Term Liabilities $2.697B $2.704B
YoY Change 8.31% 6.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $294.9M $258.2M
Total Long-Term Liabilities $2.697B $2.704B
Total Liabilities $3.014B $2.962B
YoY Change 9.72% 6.64%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $5.789B $5.785B
YoY Change 0.14% 1.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.581B $4.599B
YoY Change
Total Liabilities & Shareholders Equity $7.596B $7.583B
YoY Change 2.92% 3.03%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $22.62M $22.20M
YoY Change -33.57% -20.68%
Depreciation, Depletion And Amortization $80.27M $75.77M
YoY Change 14.9% 7.1%
Cash From Operating Activities $134.6M $26.49M
YoY Change 0.76% 9.82%
INVESTING ACTIVITIES
Capital Expenditures $64.42M $69.86M
YoY Change -168.22% -189.82%
Acquisitions
YoY Change
Other Investing Activities $8.592M -$23.98M
YoY Change -257.54% 52.9%
Cash From Investing Activities -$55.82M -$93.85M
YoY Change -44.11% 0.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -74.31M $65.79M
YoY Change 102.88% -2.39%
NET CHANGE
Cash From Operating Activities 134.6M $26.49M
Cash From Investing Activities -55.82M -$93.85M
Cash From Financing Activities -74.31M $65.79M
Net Change In Cash 4.446M -$1.560M
YoY Change -251.07% -19.46%
FREE CASH FLOW
Cash From Operating Activities $134.6M $26.49M
Capital Expenditures $64.42M $69.86M
Free Cash Flow $70.16M -$43.37M
YoY Change -69.23% -142.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000025232
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-11312
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
COUSINS PROPERTIES INC
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-0869052
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3344 Peachtree Road NE
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30326-4802
CY2023Q1 dei City Area Code
CityAreaCode
404
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
407-1000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
CUZ
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
151693864 shares
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1131555000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1079662000 usd
CY2023Q1 us-gaap Rental Properties
RentalProperties
6744701000 usd
CY2022Q4 us-gaap Rental Properties
RentalProperties
6738354000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
119291000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
111400000 usd
CY2023Q1 cuz Land Held
LandHeld
158430000 usd
CY2022Q4 cuz Land Held
LandHeld
158430000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7022422000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7008184000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3585000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5145000 usd
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
9634000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
8653000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
192713000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
184043000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
136721000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
112839000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
129838000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
136240000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
88057000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
81912000 usd
CY2023Q1 us-gaap Assets
Assets
7582970000 usd
CY2022Q4 us-gaap Assets
Assets
7537016000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2448942000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2334606000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
205018000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
271103000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
154088000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
128636000 usd
CY2023Q1 cuz Intangible Liabilities
IntangibleLiabilities
49831000 usd
CY2022Q4 cuz Intangible Liabilities
IntangibleLiabilities
52280000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
104055000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
103442000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2961934000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2890067000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154255888 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154019214 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151693864 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151457190 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
154256000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
154019000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5631076000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5630327000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2562024 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2562024 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
147157000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
147157000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1039694000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1013292000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
537000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1767000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4599018000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4625664000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
22018000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
21285000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4621036000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646949000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7582970000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7537016000 usd
CY2023Q1 us-gaap Revenues
Revenues
202728000 usd
CY2022Q1 us-gaap Revenues
Revenues
186898000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
71213000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64877000 usd
CY2023Q1 cuz Reimbursed Expenses
ReimbursedExpenses
207000 usd
CY2022Q1 cuz Reimbursed Expenses
ReimbursedExpenses
360000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8438000 usd
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8063000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
15525000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70744000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
385000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
221000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
181043000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
159790000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1124000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-2000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-69000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
160000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
179000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22196000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27984000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148739000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151880000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149002000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22196000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
27984000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1041000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
189000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1230000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20966000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27984000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646949000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1230000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2138000 usd
CY2023Q1 cuz Amortization Of Stock Based Compensation Net Of Forfeitures
AmortizationOfStockBasedCompensationNetOfForfeitures
-3124000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
738000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
165000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
48598000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4621036000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4600400000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-930000 usd
CY2022Q1 cuz Amortization Of Stock Based Compensation Net Of Forfeitures
AmortizationOfStockBasedCompensationNetOfForfeitures
-2416000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1279000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
86000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
48597000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4582645000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-69000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70744000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1021000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
51000 usd
CY2023Q1 cuz Net Amortization Of Stock Options And Restricted Stock
NetAmortizationOfStockOptionsAndRestrictedStock
3559000 usd
CY2022Q1 cuz Net Amortization Of Stock Options And Restricted Stock
NetAmortizationOfStockOptionsAndRestrictedStock
2748000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
11193000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
8445000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1124000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1299000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1924000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8407000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12029000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-57240000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-57976000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26494000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24125000 usd
CY2023Q1 cuz Payments To Acquire And Develop Real Estate And Tenant Asset Expenditures
PaymentsToAcquireAndDevelopRealEstateAndTenantAssetExpenditures
69863000 usd
CY2022Q1 cuz Payments To Acquire And Develop Real Estate And Tenant Asset Expenditures
PaymentsToAcquireAndDevelopRealEstateAndTenantAssetExpenditures
77779000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
23984000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
15686000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93847000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93465000 usd
CY2023Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
165000000 usd
CY2022Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
152000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49300000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35500000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2041000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4197000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
32000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
48407000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
46093000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
738000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1279000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
165000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
86000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65793000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67403000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1560000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1937000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5145000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10168000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3585000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8231000 usd
CY2023Q1 cuz Distribution Of Taxable Income To Qualify As Reit Minimum
DistributionOfTaxableIncomeToQualifyAsREITMinimum
1
CY2023Q1 cuz Portfolio Of Real Estate Assets Office Space Area
PortfolioOfRealEstateAssetsOfficeSpaceArea
18800000 sqft
CY2023Q1 cuz Portfolio Of Real Estate Assets Retail Space Area
PortfolioOfRealEstateAssetsRetailSpaceArea
310000 sqft
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
136240000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1674000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1674000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
129838000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000 usd
CY2023Q1 cuz Predevelopment Costs And Earnest Money
PredevelopmentCostsAndEarnestMoney
51556000 usd
CY2022Q4 cuz Predevelopment Costs And Earnest Money
PredevelopmentCostsAndEarnestMoney
50009000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11781000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6438000 usd
CY2023Q1 cuz Furniture Fixture And Equipment And Leasehold Improvements Accumulated Depreciation
FurnitureFixtureAndEquipmentAndLeaseholdImprovementsAccumulatedDepreciation
18412000 usd
CY2022Q4 cuz Furniture Fixture And Equipment And Leasehold Improvements Accumulated Depreciation
FurnitureFixtureAndEquipmentAndLeaseholdImprovementsAccumulatedDepreciation
18860000 usd
CY2023Q1 cuz Furniture Fixture And Equipment And Leasehold Improvements
FurnitureFixtureAndEquipmentAndLeaseholdImprovements
11467000 usd
CY2022Q4 cuz Furniture Fixture And Equipment And Leasehold Improvements
FurnitureFixtureAndEquipmentAndLeaseholdImprovements
11824000 usd
CY2023Q1 cuz Accumulated Amortization Incentives To Lessees
AccumulatedAmortizationIncentivesToLessees
5615000 usd
CY2022Q4 cuz Accumulated Amortization Incentives To Lessees
AccumulatedAmortizationIncentivesToLessees
5129000 usd
CY2023Q1 us-gaap Incentive To Lessee
IncentiveToLessee
8014000 usd
CY2022Q4 us-gaap Incentive To Lessee
IncentiveToLessee
8091000 usd
CY2023Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1167000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
135000 usd
CY2023Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
5239000 usd
CY2022Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
5550000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
88057000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
81912000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2455501000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2341841000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6559000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7235000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2448942000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2334606000 usd
CY2023Q1 cuz Debt Instrument Weighted Average Maturity Period
DebtInstrumentWeightedAverageMaturityPeriod
P3Y9M18D
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2300000000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2200000000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
30121000 usd
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
18976000 usd
CY2023Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
5091000 usd
CY2022Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
3451000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25030000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
15525000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1041000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
189000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
15525000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
53225000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
53129000 usd
CY2023Q1 us-gaap Advance Rent
AdvanceRent
35262000 usd
CY2022Q4 us-gaap Advance Rent
AdvanceRent
33165000 usd
CY2023Q1 us-gaap Lease Deposit Liability
LeaseDepositLiability
13709000 usd
CY2022Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
14635000 usd
CY2023Q1 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
1048000 usd
CY2023Q1 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1859000 usd
CY2022Q4 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1465000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
104055000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
103442000 usd
CY2023Q1 cuz Outstanding Letters Of Credit And Performance Bonds
OutstandingLettersOfCreditAndPerformanceBonds
687000 usd
CY2023Q1 cuz Outstanding Commitments To Fund Real Estate Projects
OutstandingCommitmentsToFundRealEstateProjects
172400000 usd
CY2021Q3 cuz Sale Of Stock Number Of Participating Financial Institutions
SaleOfStockNumberOfParticipatingFinancialInstitutions
6 financial_institution
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3572000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2895000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22196000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
27984000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148739000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22200000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
27990000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148739000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151880000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149002000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33219000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
24179000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48600000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48597000 usd
CY2023Q1 cuz Tenant Improvements Recorded In Deferred Income
TenantImprovementsRecordedInDeferredIncome
26943000 usd
CY2022Q1 cuz Tenant Improvements Recorded In Deferred Income
TenantImprovementsRecordedInDeferredIncome
1857000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3585000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5145000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130136000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
119607000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
28163000 usd
CY2023Q1 cuz Net Operating Income From Unconsolidated Joint Ventures
NetOperatingIncomeFromUnconsolidatedJointVentures
1409000 usd
CY2022Q1 cuz Net Operating Income From Unconsolidated Joint Ventures
NetOperatingIncomeFromUnconsolidatedJointVentures
2719000 usd
CY2023Q1 cuz Reimbursed Expenses
ReimbursedExpenses
207000 usd
CY2022Q1 cuz Reimbursed Expenses
ReimbursedExpenses
360000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8438000 usd
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8063000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
15525000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70744000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
385000 usd
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
221000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1124000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-2000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-69000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130136000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
119607000 usd

Files In Submission

Name View Source Status
0000025232-23-000035-index-headers.html Edgar Link pending
0000025232-23-000035-index.html Edgar Link pending
0000025232-23-000035.txt Edgar Link pending
0000025232-23-000035-xbrl.zip Edgar Link pending
cuz-20230331.htm Edgar Link pending
cuz-20230331.xsd Edgar Link pending
cuz-exhibit3111q2023.htm Edgar Link pending
cuz-exhibit3121q2023.htm Edgar Link pending
cuz-exhibit3211q2023.htm Edgar Link pending
cuz-exhibit3221q2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
cuz-20230331_def.xml Edgar Link unprocessable
cuz-20230331_cal.xml Edgar Link unprocessable
cuz-20230331_lab.xml Edgar Link unprocessable
cuz-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cuz-20230331_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending